Inflammation induced by infection potentiates tau pathological features in transgenic mice.

Comorbidities that promote the progression of Alzheimer's disease (AD) remain to be uncovered and evaluated in animal models. Because elderly individuals are vulnerable to viral and bacterial infections, these microbial agents may be considered important comorbidities that could potentiate an already existing and tenuous inflammatory condition in the brain, accelerating cognitive decline, particularly if the cellular and molecular mechanisms can be defined. Researchers have recently demonstrated that triggering inflammation in the brain exacerbates tau pathological characteristics in animal models. Herein, we explore whether inflammation induced via viral infection, compared with inflammation induced via bacterial lipopolysaccharide, modulates AD-like pathological features in the 3xTg-AD mouse model and provide evidence to support the hypothesis that infectious agents may act as a comorbidity for AD. Our study shows that infection-induced acute or chronic inflammation significantly exacerbates tau pathological characteristics, with chronic inflammation leading to impairments in spatial memory. Tau phosphorylation was increased via a glycogen synthase kinase-3β-dependent mechanism, and there was a prominent shift of tau from the detergent-soluble to the detergent-insoluble fraction. During chronic inflammation, we found that inhibiting glycogen synthase kinase-3β activity with lithium reduced tau phosphorylation and the accumulation of insoluble tau and reversed memory impairments. Taken together, infectious agents that trigger central nervous system inflammation may serve as a comorbidity for AD, leading to cognitive impairments by a mechanism that involves exacerbation of tau pathological characteristics.

[1]  M. Wozniak,et al.  Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2009, Alzheimer's & Dementia.

[2]  M. Tsolaki,et al.  Relationship between Helicobacter pylori infection and Alzheimer disease , 2006, Neurology.

[3]  V. Thulasiraman,et al.  Use of an antibody-coupled array and mass spectrometry for simultaneous detection of multiple amyloid beta fragments , 2009, Alzheimer's & Dementia.

[4]  F. LaFerla,et al.  Genetically augmenting tau levels does not modulate the onset or progression of Aβ pathology in transgenic mice , 2007, Journal of neurochemistry.

[5]  D. Morgan,et al.  Microglial Activation is Required for Aβ Clearance After Intracranial Injection of Lipopolysaccharide in APP Transgenic Mice , 2007, Journal of Neuroimmune Pharmacology.

[6]  M. Wozniak,et al.  Herpes simplex virus infection causes cellular β-amyloid accumulation and secretase upregulation , 2007, Neuroscience Letters.

[7]  D. Morgan,et al.  Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice , 2004, Experimental Neurology.

[8]  R. Maccioni,et al.  Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. , 2004, Experimental cell research.

[9]  Khadija Iqbal,et al.  Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. LaFerla,et al.  Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[11]  J. Alonso,et al.  Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. , 2002, Cellular signalling.

[12]  A. Takashima,et al.  GSK-3β Is Required for Memory Reconsolidation in Adult Brain , 2008, PLoS ONE.

[13]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[14]  C. Schaumburg,et al.  T Cell Antiviral Effector Function Is Not Dependent on CXCL10 Following Murine Coronavirus Infection1 , 2006, The Journal of Immunology.

[15]  N. Robakis,et al.  It May Take Inflammation, Phosphorylation and Ubiquitination to ‘Tangle’ in Alzheimer’s Disease , 2007, Neurodegenerative Diseases.

[16]  D. Appelt,et al.  Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice , 2004, Neurobiology of Aging.

[17]  F. LaFerla,et al.  Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. , 2007, The American journal of pathology.

[18]  M. Gurney,et al.  Tau Phosphorylation at Serine 396 and Serine 404 by Human Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote Microtubule Assembly* , 2000, The Journal of Biological Chemistry.

[19]  S. Barger,et al.  Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway , 2003, The Journal of Neuroscience.

[20]  M. Buchmeier,et al.  Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. , 1998, Journal of immunology.

[21]  E. Mandelkow,et al.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.

[22]  J. Rogers,et al.  Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. , 2006, Journal of Alzheimer's disease : JAD.

[23]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[24]  Jae Woong Lee,et al.  Journal of Neuroinflammation Neuro-inflammation Induced by Lipopolysaccharide Causes Cognitive Impairment through Enhancement of Beta-amyloid Generation , 2022 .

[25]  F. LaFerla,et al.  Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology , 2009, Neurobiology of Disease.

[26]  H. Schätzl,et al.  Lithium induces clearance of protease resistant prion protein in prion‐infected cells by induction of autophagy , 2009, Journal of neurochemistry.

[27]  S. Edland,et al.  in Alzheimer's Disease , 1994 .

[28]  Lili Wang,et al.  Interplay between Cyclin-Dependent Kinase 5 and Glycogen Synthase Kinase 3β Mediated by Neuregulin Signaling Leads to Differential Effects on Tau Phosphorylation and Amyloid Precursor Protein Processing , 2008, The Journal of Neuroscience.

[29]  S. Kikuchi,et al.  Relationship between Helicobacter pylori infection and smoking and drinking habits , 2000, Journal of gastroenterology and hepatology.

[30]  G. Cole,et al.  Scavenging of Alzheimer's amyloid β‐protein by microglia in culture , 1996, Journal of neuroscience research.

[31]  Y. L. Dubreuil,et al.  Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Q. Tian,et al.  Temporal correlation of the memory deficit with Alzheimer‐like lesions induced by activation of glycogen synthase kinase‐3 , 2008, Journal of neurochemistry.

[33]  H. Keirstead,et al.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis , 2004, Experimental Neurology.

[34]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[35]  Gabriele Siciliano,et al.  Lithium delays progression of amyotrophic lateral sclerosis , 2008, Proceedings of the National Academy of Sciences.

[36]  P. Mcgeer,et al.  Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein , 1996, Neuroscience Letters.

[37]  J. Fleming,et al.  Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated , 1990, Journal of Neuroimmunology.

[38]  John D Lambris,et al.  Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  F. LaFerla,et al.  Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase‐3β , 2008, Annals of neurology.

[40]  N. Ip,et al.  Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction , 2001, Nature Neuroscience.

[41]  F. Plattner,et al.  The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation* , 2006, Journal of Biological Chemistry.

[42]  D. Borchelt,et al.  Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid β peptide in APPswe transgenic mice , 2003, Neurobiology of Disease.

[43]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[44]  D. Appelt,et al.  Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain , 1998, Medical Microbiology and Immunology.

[45]  D. Selkoe.  Toward a remembrance of things past: deciphering Alzheimer disease. , 2003, Harvey lectures.

[46]  R. Edwards,et al.  Evidence for Differential Roles for NKG2D Receptor Signaling in Innate Host Defense against Coronavirus-Induced Neurological and Liver Disease , 2007, Journal of Virology.

[47]  L. Lue,et al.  Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease , 2001, Neurochemistry International.

[48]  S. Maeda,et al.  Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. , 2008, Current Alzheimer research.

[49]  E. Mandelkow,et al.  Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. , 1998, European journal of biochemistry.

[50]  K. Honjo,et al.  Commentary on the letter for Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2010, Alzheimer's & Dementia.

[51]  K. Honjo,et al.  Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? , 2009, Alzheimer's & Dementia.

[52]  M. Mattson,et al.  Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[53]  D. Rubinsztein,et al.  Lithium induces autophagy by inhibiting inositol monophosphatase , 2005, The Journal of cell biology.

[54]  C. Holmes,et al.  Role of Infection in the Pathogenesis of Alzheimer’s Disease , 2009, CNS drugs.

[55]  M. Wozniak,et al.  Herpes simplex virus type 1 in Alzheimer's disease: the enemy within , 2009, BDJ.

[56]  C. Tzourio,et al.  Vascular risk factors and dementia , 2009, Neurology.

[57]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[58]  C. Geula,et al.  Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.

[59]  D. Ruano,et al.  Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic , 2008, The Journal of Neuroscience.